When is cerebrospinal fluid (CSF) biomarker testing the best choice for diagnosing Alzheimer&#x27;s disease (AD)?<br>Credit available for this activity expires: 8/19/27<br>Earn Credit / Learning Objectives &amp; Disclosures: https://www.medscape.org/viewarticle/alzheimers-disease-precision-diagnostics-3-part-live-2026a1000rmh?ecd=bdc_podcast_libsyn_mscpedu

Alzheimer's Disease Precision Diagnostics: A 3-Part Live Masterclass: Part 2 - Cerebrospinal Fluid Biomarkers

Keeping Current CME

Prior to beginning the activity, please be sure to review the faculty information and disclosure statements, as well as the learning objectives. After listening to the activity, complete the post-test by clicking the Earn Credit link in the episode description. Downloadable slides and resources are also available.

The following presentation is copyrighted by Medscape. No use, broadcast or recording of this presentation, or any part thereof, is permitted without the written authorization of Medscape. The following presentation is part of a certified educational activity provided by Medscape Education and supported by an independent educational grant from Lili.

Good afternoon, everybody. We are here today to talk about the Alzheimer's Disease Precision Diagnostics. This is part two on cerebral spinal fluid biomarkers. I'm Dr. Ana Pereira, I'm a cognitive neurologist and neuroscientist at Mount Sinai School of Medicine. And we're excited to have you all here. This program has been supported by an educational grant from Eli Lilly.

We'll talk about cerebral spinal fluid biomarker testing for diagnosis and when to use it and a lot of the nuances of this. We have had a lecture on amyloid PET. And in August, Dr. Suzanne Schimble will be giving a talk on plasma blood biomarkers for Alzheimer's disease.

So, as you know, Alzheimer's disease, it's in the continuum. You can have cognitive unimpaired patients who are normal. Then you have an MCI, myocognitive impairment, in which patients have some domain of cognitive impairment, but still can function in daily life, activities of daily living. And you have dementia, and you have dementia, and it impairs activity of daily living, such as paying bills, taking care of medication, and so on and so forth.

Alzheimer's Disease Precision Diagnostics: A 3-Part Live Masterclass: Part 2 - Cerebrospinal Fluid Biomarkers

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Alzheimer's Disease Precision Diagnostics: A 3-Part Live Masterclass: Part 2 - Cerebrospinal Fluid Biomarkers

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.